China · Delayed Price · Currency is CNY Sino Biological,Inc. Statistics
Total Valuation
SHE:301047 has a market cap or net worth of CNY 12.12 billion. The enterprise value is 9.03 billion.
| Market Cap | 12.12B |
| Enterprise Value | 9.03B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | May 15, 2026 |
Share Statistics
SHE:301047 has 121.64 million shares outstanding. The number of shares has decreased by -2.35% in one year.
| Current Share Class | 121.64M |
| Shares Outstanding | 121.64M |
| Shares Change (YoY) | -2.35% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 55.81% |
| Owned by Institutions (%) | 1.87% |
| Float | 43.30M |
Valuation Ratios
The trailing PE ratio is 73.34 and the forward PE ratio is 59.66.
| PE Ratio | 73.34 |
| Forward PE | 59.66 |
| PS Ratio | 15.78 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 2.46 |
| P/FCF Ratio | 170.69 |
| P/OCF Ratio | 57.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 44.06, with an EV/FCF ratio of 127.21.
| EV / Earnings | 54.65 |
| EV / Sales | 11.76 |
| EV / EBITDA | 44.06 |
| EV / EBIT | 70.28 |
| EV / FCF | 127.21 |
Financial Position
The company has a current ratio of 25.42, with a Debt / Equity ratio of 0.01.
| Current Ratio | 25.42 |
| Quick Ratio | 24.67 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | 0.56 |
| Interest Coverage | 41.62 |
Financial Efficiency
Return on equity (ROE) is 3.01% and return on invested capital (ROIC) is 4.82%.
| Return on Equity (ROE) | 3.01% |
| Return on Assets (ROA) | 1.41% |
| Return on Invested Capital (ROIC) | 4.82% |
| Return on Capital Employed (ROCE) | 2.42% |
| Weighted Average Cost of Capital (WACC) | 8.42% |
| Revenue Per Employee | 718,430 |
| Profits Per Employee | 154,578 |
| Employee Count | 1,069 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 2.59 |
Taxes
In the past 12 months, SHE:301047 has paid 40.67 million in taxes.
| Income Tax | 40.67M |
| Effective Tax Rate | 19.75% |
Stock Price Statistics
The stock price has increased by +14.65% in the last 52 weeks. The beta is 0.76, so SHE:301047's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +14.65% |
| 50-Day Moving Average | 89.49 |
| 200-Day Moving Average | 74.85 |
| Relative Strength Index (RSI) | 50.15 |
| Average Volume (20 Days) | 10,338,035 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301047 had revenue of CNY 768.00 million and earned 165.24 million in profits. Earnings per share was 1.36.
| Revenue | 768.00M |
| Gross Profit | 563.37M |
| Operating Income | 128.50M |
| Pretax Income | 205.91M |
| Net Income | 165.24M |
| EBITDA | 191.05M |
| EBIT | 128.50M |
| Earnings Per Share (EPS) | 1.36 |
Balance Sheet
The company has 3.13 billion in cash and 40.09 million in debt, with a net cash position of 3.09 billion or 25.38 per share.
| Cash & Cash Equivalents | 3.13B |
| Total Debt | 40.09M |
| Net Cash | 3.09B |
| Net Cash Per Share | 25.38 |
| Equity (Book Value) | 5.23B |
| Book Value Per Share | 43.02 |
| Working Capital | 3.29B |
Cash Flow
In the last 12 months, operating cash flow was 209.14 million and capital expenditures -138.15 million, giving a free cash flow of 71.00 million.
| Operating Cash Flow | 209.14M |
| Capital Expenditures | -138.15M |
| Depreciation & Amortization | 62.55M |
| Net Borrowing | -31.09M |
| Free Cash Flow | 71.00M |
| FCF Per Share | 0.58 |
Margins
Gross margin is 73.35%, with operating and profit margins of 16.73% and 21.52%.
| Gross Margin | 73.35% |
| Operating Margin | 16.73% |
| Pretax Margin | 26.81% |
| Profit Margin | 21.52% |
| EBITDA Margin | 24.88% |
| EBIT Margin | 16.73% |
| FCF Margin | 9.24% |
Dividends & Yields
This stock pays an annual dividend of 5.20, which amounts to a dividend yield of 5.50%.
| Dividend Per Share | 5.20 |
| Dividend Yield | 5.50% |
| Dividend Growth (YoY) | 420.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 382.78% |
| Buyback Yield | 2.35% |
| Shareholder Yield | 7.85% |
| Earnings Yield | 1.36% |
| FCF Yield | 0.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2022. It was a forward split with a ratio of 1.9.
| Last Split Date | Mar 30, 2022 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |